Evgen Pharma Share Chat (EVG)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Evgen Pharma	LSE:EVG	London	Ordinary Share	GB00BSVYN304	ORD 0.25P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	13.00p	12.50p	13.50p	13.00p	13.00p	13.00p	0	06:35:19

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-3.6	-4.2	-	12.13

Evgen Pharma Share Discussion Threads

Showing 551 to 574 of 575 messages

Chat Pages: 23 22 21 20 19 18 17 16 15 14 13 12 Older

Date	Subject	Author	Discuss
24/4/2018 09:32	RNS 24 April 2018: The presentation will also refer to the ongoing Phase II trial of SFX-01 in metastatic breast cancer, which is on track to report an interim read-out in Q2 this year with the final read-out around the year end.	vatnabrekk	Read Full Thread Reply
12/4/2018 15:49	does this company make any money? -12% since the start of the year.	wwick	Read Full Thread Reply
12/4/2018 12:02	apparently CEO doing proactive event in may.so H1 results could be early?	moneytree1	Read Full Thread Reply
10/4/2018 09:28	Inflection point soon with narrowing trade channel, we're set for a break out one way or t'other... an RNS in the next week or so would be useful.	rathean	Read Full Thread Reply
21/3/2018 14:01	ppl keep selling.	moneytree1	Read Full Thread Reply
08/3/2018 13:05	Why does this keep falling?	wins73	Read Full Thread Reply
07/3/2018 12:24	Joined you guys with an initial 45700. Market cap seems way too cheap at £12 million. This could do an N4P once momentum builds.	parob	Read Full Thread Reply
02/3/2018 12:13	IPO was nearly 40p and broker target is nearly 100p So there's plenty of headroom here and barely off the ground from it's lowest lows. looking at the chart when it gets going it really moves.	saw89	Read Full Thread Reply
02/3/2018 10:38	More sustained buying, could see 20p again before the results.	rathean	Read Full Thread Reply
01/3/2018 17:00	From the interim results they said; "Early stage pipeline - In collaboration with the medicinal chemists at the University of Seville we have created a range of novel compounds based upon the sulforaphane core structure. Evgen has in-licensed the Seville intellectual property presenting us with multiple new chemical entities based upon sulforaphane. Screening of a series of such novel, proprietary, sulforaphane analogues is underway at the University of Liverpool and the full dataset will be evaluated during Q1 of calendar year 2018." I see the Uni of Seville have just released some research which may be relevant to this; "NMR study on the stabilization and chiral discrimination of sulforaphane enantiomers and analogues by cyclodextrins" hTTps://www.sciencedirect.com/science/article/pii/S0144861717314285?via%3Dihub Hopefully a step forward in the science.	pdt	Read Full Thread Reply
01/3/2018 10:20	Yes, there is certainly a pick up in the volume of trades. The Capital Network report above suggested that the interim cancer trial readout may be the trigger for licencing activity before the full results at the end of the year. I think there is growing interest in targeting cancer stem cells. The recent University of Manchester poster on SFX-01 at the Breast Cancer Conference was positive and I see Stephen Franklin was interviewed in a recent Cancer Stem Cell report. Interesting times :)	pdt	Read Full Thread Reply
01/3/2018 10:10	Q1 screening of cancer cells utilising the Sulforadex technology full data readout due in next 4 weeks see page 3 of report, H1 breast cancer interim phase 2 trial readout positioning ahead of news...could get interesting.gl	moneytree1	Read Full Thread Reply
01/3/2018 09:00	Nice volume this morning, leaky broker ahead of rns wouldn't surprise me.	rathean	Read Full Thread Reply
22/2/2018 12:04	http://www.capitalnetwork.com/companies/research/110586/evgen-pharma-plc-harnessing-sulforaphane-s-therapeutic-properties-110586.html	ohisay	Read Full Thread Reply
30/1/2018 11:19	I think it will slip below the 12p placing price as the placing shares are flipped for a nice profit especially with full trial readout not for another 11 months	lambo222	Read Full Thread Reply
30/1/2018 09:30	Slipping back to floor support levels, good price to buy in ahead of next RNS.	rathean	Read Full Thread Reply
15/1/2018 13:09	The Breast Cancer conference has a PDF available on it's website. The poster information is on page 80 hTTp://breastcancerconference.org/wp-content/uploads/2018/01/UK-IBCS-Published-Abstracts.pdf On the same page is a study by AstraZeneca doing a similar study with Progesterone receptor antagonists to inhibit cancer stem cell activity. I would be interested to know how they compare.	pdt	Read Full Thread Reply
15/1/2018 07:39	More scientific evidence released today by the company supporting their Breast cancer treatment. I think the Hardman report estimated the market for this treatment at $5 billion per annum. Look forward to the interim phase II read out by June this year. Early signs are that it works and increasingly they are providing the science of why it works. Hugely important to breast cancer patients.	pdt	Read Full Thread Reply
12/1/2018 20:29	Another study showing the effectiveness against cancer stem cells; "Sulforaphane reverses gefitinib tolerance in human lung cancer cells via modulation of sonic hedgehog signaling" hTTps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738694/ Gefitinib is marketed by Astrazeneca under the trade name Iressa. Currently doing $500m per annum in sales.	pdt	Read Full Thread Reply
12/1/2018 11:41	Chart suggests we're just off the bottom. Any positive news will see it 25p again.	rathean	Read Full Thread Reply
05/1/2018 20:35	3.4m shares still need to be declared	dave444	Read Full Thread Reply
04/1/2018 09:31	Surprised that no holding statements have been declared after fundraising	dave444	Read Full Thread Reply
13/12/2017 10:16	Agreed #Tilly99, share price discounts huge upside. Great entry point, it'll rise quickly when it goes	rathean	Read Full Thread Reply
13/12/2017 08:50	Floated at 37p? And only had good news since	tilly99	Read Full Thread Reply

Chat Pages: 23 22 21 20 19 18 17 16 15 14 13 12 Older

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.